Fructose improves the ability of hyperglycemia per se to regulate glucose production in type 2 diabetes

Meredith A. Hawkins, Ilan Gabriely, Robert Wozniak, Cristian Vilcu, Harry Shamoon, Luciano Rossetti

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

The ability of hyperglycemia per se to suppress endogenous glucose production (GP) is blunted in type 2 diabetes. This could be due in part to decreased glucose-induced flux through glucokinase (GK). Because fructose activates hepatic GK, we examined whether catalytic amounts of fructose could restore inhibition of GP by hyperglycemia in humans with type 2 diabetes. Glucose fluxes ([3-3H]glucose) were measured during euglycemia (5 mmol/l) and after abrupt onset of hyperglycemia (10 mmol/l; variable dextrose infusion) under fixed hormonal conditions (somatostatin infusion for 6 h with basal insulin/glucagon/growth hormone replacement). A total of 10 subjects with moderately controlled type 2 diabetes and 7 age- and BMI-matched nondiabetic subjects were studied on up to three separate occasions under the following conditions: without fructose (F-) or with infusion of fructose at two dosages: 0.6 mg/kg·min (low F) and 1.8 mg/kg·min (high F). Although GP failed to decrease in response to hyperglycemia in type 2 diabetes, the coinfusion of both doses of fructose was associated with comparable decreases in GP in response to hyperglycemia (low F = -27%, high F = -33%; P < 0.01 vs. F- at both dosages), which approached the 44% decline in GP observed without fructose in the nondiabetic subjects. GP responses to hyperglycemia were not altered by the addition of fructose in the nondiabetic group (low F = -47%, high F = -42%; P > 0.05 vs. F-). Thus, the administration of small amounts of fructose to type 2 diabetic subjects partially corrected the regulation of GP by hyperglycemia per se, yet did not affect this regulation in the nondiabetic subjects. This suggests that the liver's inability to respond to hyperglycemia in type 2 diabetes, likely caused by impaired GK activity, contributes substantially to the increased GP in these individuals.

Original languageEnglish (US)
Pages (from-to)606-614
Number of pages9
JournalDiabetes
Volume51
Issue number3
StatePublished - 2002

Fingerprint

Fructose
Hyperglycemia
Type 2 Diabetes Mellitus
Glucose
Glucokinase
Liver
Somatostatin
Glucagon
Growth Hormone
Insulin

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Fructose improves the ability of hyperglycemia per se to regulate glucose production in type 2 diabetes. / Hawkins, Meredith A.; Gabriely, Ilan; Wozniak, Robert; Vilcu, Cristian; Shamoon, Harry; Rossetti, Luciano.

In: Diabetes, Vol. 51, No. 3, 2002, p. 606-614.

Research output: Contribution to journalArticle

Hawkins, MA, Gabriely, I, Wozniak, R, Vilcu, C, Shamoon, H & Rossetti, L 2002, 'Fructose improves the ability of hyperglycemia per se to regulate glucose production in type 2 diabetes', Diabetes, vol. 51, no. 3, pp. 606-614.
Hawkins, Meredith A. ; Gabriely, Ilan ; Wozniak, Robert ; Vilcu, Cristian ; Shamoon, Harry ; Rossetti, Luciano. / Fructose improves the ability of hyperglycemia per se to regulate glucose production in type 2 diabetes. In: Diabetes. 2002 ; Vol. 51, No. 3. pp. 606-614.
@article{4ed1459dda5149e3bdf9b0f6f3350e3c,
title = "Fructose improves the ability of hyperglycemia per se to regulate glucose production in type 2 diabetes",
abstract = "The ability of hyperglycemia per se to suppress endogenous glucose production (GP) is blunted in type 2 diabetes. This could be due in part to decreased glucose-induced flux through glucokinase (GK). Because fructose activates hepatic GK, we examined whether catalytic amounts of fructose could restore inhibition of GP by hyperglycemia in humans with type 2 diabetes. Glucose fluxes ([3-3H]glucose) were measured during euglycemia (5 mmol/l) and after abrupt onset of hyperglycemia (10 mmol/l; variable dextrose infusion) under fixed hormonal conditions (somatostatin infusion for 6 h with basal insulin/glucagon/growth hormone replacement). A total of 10 subjects with moderately controlled type 2 diabetes and 7 age- and BMI-matched nondiabetic subjects were studied on up to three separate occasions under the following conditions: without fructose (F-) or with infusion of fructose at two dosages: 0.6 mg/kg·min (low F) and 1.8 mg/kg·min (high F). Although GP failed to decrease in response to hyperglycemia in type 2 diabetes, the coinfusion of both doses of fructose was associated with comparable decreases in GP in response to hyperglycemia (low F = -27{\%}, high F = -33{\%}; P < 0.01 vs. F- at both dosages), which approached the 44{\%} decline in GP observed without fructose in the nondiabetic subjects. GP responses to hyperglycemia were not altered by the addition of fructose in the nondiabetic group (low F = -47{\%}, high F = -42{\%}; P > 0.05 vs. F-). Thus, the administration of small amounts of fructose to type 2 diabetic subjects partially corrected the regulation of GP by hyperglycemia per se, yet did not affect this regulation in the nondiabetic subjects. This suggests that the liver's inability to respond to hyperglycemia in type 2 diabetes, likely caused by impaired GK activity, contributes substantially to the increased GP in these individuals.",
author = "Hawkins, {Meredith A.} and Ilan Gabriely and Robert Wozniak and Cristian Vilcu and Harry Shamoon and Luciano Rossetti",
year = "2002",
language = "English (US)",
volume = "51",
pages = "606--614",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "3",

}

TY - JOUR

T1 - Fructose improves the ability of hyperglycemia per se to regulate glucose production in type 2 diabetes

AU - Hawkins, Meredith A.

AU - Gabriely, Ilan

AU - Wozniak, Robert

AU - Vilcu, Cristian

AU - Shamoon, Harry

AU - Rossetti, Luciano

PY - 2002

Y1 - 2002

N2 - The ability of hyperglycemia per se to suppress endogenous glucose production (GP) is blunted in type 2 diabetes. This could be due in part to decreased glucose-induced flux through glucokinase (GK). Because fructose activates hepatic GK, we examined whether catalytic amounts of fructose could restore inhibition of GP by hyperglycemia in humans with type 2 diabetes. Glucose fluxes ([3-3H]glucose) were measured during euglycemia (5 mmol/l) and after abrupt onset of hyperglycemia (10 mmol/l; variable dextrose infusion) under fixed hormonal conditions (somatostatin infusion for 6 h with basal insulin/glucagon/growth hormone replacement). A total of 10 subjects with moderately controlled type 2 diabetes and 7 age- and BMI-matched nondiabetic subjects were studied on up to three separate occasions under the following conditions: without fructose (F-) or with infusion of fructose at two dosages: 0.6 mg/kg·min (low F) and 1.8 mg/kg·min (high F). Although GP failed to decrease in response to hyperglycemia in type 2 diabetes, the coinfusion of both doses of fructose was associated with comparable decreases in GP in response to hyperglycemia (low F = -27%, high F = -33%; P < 0.01 vs. F- at both dosages), which approached the 44% decline in GP observed without fructose in the nondiabetic subjects. GP responses to hyperglycemia were not altered by the addition of fructose in the nondiabetic group (low F = -47%, high F = -42%; P > 0.05 vs. F-). Thus, the administration of small amounts of fructose to type 2 diabetic subjects partially corrected the regulation of GP by hyperglycemia per se, yet did not affect this regulation in the nondiabetic subjects. This suggests that the liver's inability to respond to hyperglycemia in type 2 diabetes, likely caused by impaired GK activity, contributes substantially to the increased GP in these individuals.

AB - The ability of hyperglycemia per se to suppress endogenous glucose production (GP) is blunted in type 2 diabetes. This could be due in part to decreased glucose-induced flux through glucokinase (GK). Because fructose activates hepatic GK, we examined whether catalytic amounts of fructose could restore inhibition of GP by hyperglycemia in humans with type 2 diabetes. Glucose fluxes ([3-3H]glucose) were measured during euglycemia (5 mmol/l) and after abrupt onset of hyperglycemia (10 mmol/l; variable dextrose infusion) under fixed hormonal conditions (somatostatin infusion for 6 h with basal insulin/glucagon/growth hormone replacement). A total of 10 subjects with moderately controlled type 2 diabetes and 7 age- and BMI-matched nondiabetic subjects were studied on up to three separate occasions under the following conditions: without fructose (F-) or with infusion of fructose at two dosages: 0.6 mg/kg·min (low F) and 1.8 mg/kg·min (high F). Although GP failed to decrease in response to hyperglycemia in type 2 diabetes, the coinfusion of both doses of fructose was associated with comparable decreases in GP in response to hyperglycemia (low F = -27%, high F = -33%; P < 0.01 vs. F- at both dosages), which approached the 44% decline in GP observed without fructose in the nondiabetic subjects. GP responses to hyperglycemia were not altered by the addition of fructose in the nondiabetic group (low F = -47%, high F = -42%; P > 0.05 vs. F-). Thus, the administration of small amounts of fructose to type 2 diabetic subjects partially corrected the regulation of GP by hyperglycemia per se, yet did not affect this regulation in the nondiabetic subjects. This suggests that the liver's inability to respond to hyperglycemia in type 2 diabetes, likely caused by impaired GK activity, contributes substantially to the increased GP in these individuals.

UR - http://www.scopus.com/inward/record.url?scp=0036310219&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036310219&partnerID=8YFLogxK

M3 - Article

C2 - 11872657

AN - SCOPUS:0036310219

VL - 51

SP - 606

EP - 614

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 3

ER -